Has Saundra Stock, MD received payments from drug or device companies?

Yes. Drug and device makers reported $1,774 in general payments to Saundra Stock, MD across 15 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Saundra Stock, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Saundra Stock, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Saundra Stock, MD

Child & Adolescent Psychiatry · Tampa, FLNPI 1659485597

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 15 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 11 manufacturers, the largest accounting for just 19.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $500 and has fallen 77.1% since, to $115 in 2025.

$1,774in general payments, 2019–2025

Across 15 payments — averaging $118.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Corium, LLC$351
Ironshore Pharmaceuticals Inc.$261
Neos Therapeutics, LP$246
Tris Pharma Inc$125
Noven Pharmaceuticals, Inc.$125
Johnson & Johnson$124
plus $542 from 5 others

What the payments were for

Food & beverage$1,774100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Corium, LLC	3	$351
Ironshore Pharmaceuticals Inc.	2	$261
Neos Therapeutics, LP	2	$246
Tris Pharma Inc	1	$125
Noven Pharmaceuticals, Inc.	1	$125
Johnson & Johnson	1	$124
Supernus Pharmaceuticals, Inc.	1	$123
Alkermes, Inc.	1	$116
Vanda Pharmaceuticals Inc.	1	$115
Otsuka Pharmaceutical Development & Commercialization, Inc.	1	$106
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	1	$83

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

ARISTADA$464
Azstarys$351
JORNAY PM$140
Dyanavel XR$125
Xelstrym$125
SPRAVATO$124
Adzenys XR-ODT$124
QELBREE$123
Cotempla XR-ODT$122
Jornay PM 20mg capsules (Bottle of 100)$122
ARISTADA INITIO$116
Fanapt$115

How this compares

$1,774 in reported general payments places this provider in the 70th percentile of 206 child & adolescent psychiatry providers in Florida.

See all child & adolescent psychiatry providers in Florida →

Medicare billing

Part B allowed, 2024

$3,696

Medicare patients

Services billed

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
AustedoDeutetrabenazine	11	$61,212
Aripiprazole OdtAripiprazole	13	$6,862
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine	28	$1,993
Quetiapine Fumarate ErQuetiapine Fumarate	21	$1,327
Divalproex Sodium ErDivalproex Sodium	26	$756
Zolpidem Tartrate	14	$230
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine	25	$206
Lithium Carbonate	11	$157
Escitalopram Oxalate	13	$132
Metformin Hcl	17	$120
Sertraline Hcl	12	$109
Quetiapine Fumarate	12	$60
Alprazolam	15	$54

Paid to pharmacies, not to this prescriber.

Other child & adolescent psychiatry in Tampa

Vashaun WilliamsTampa$5K
Megan ToufexisTampa$4K
Reena ThomasTampa$4K
Neil ThierryTampa$4K
Leigh RuthTampa$3K
Phyllis FeldmanTampa$2K
Craig KuninsGulfport$265K
Elias SarkisGainesville$169K
Jeffrey AlvaroSt Petersburg$87K
Rosa Negron MunozLakeland$39K

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →